Mainz Biomed (MYNZ) Cash & Current Investments (2020 - 2025)
Historic Cash & Current Investments for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $1.9 million.
- Mainz Biomed's Cash & Current Investments rose 9545.3% to $1.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year increase of 9545.3%. This contributed to the annual value of $6.2 million for FY2024, which is 1181.25% down from last year.
- According to the latest figures from Q2 2025, Mainz Biomed's Cash & Current Investments is $1.9 million, which was up 9545.3% from $6.2 million recorded in Q4 2024.
- In the past 5 years, Mainz Biomed's Cash & Current Investments ranged from a high of $17.1 million in Q4 2022 and a low of $977764.0 during Q2 2024
- Its 5-year average for Cash & Current Investments is $9.3 million, with a median of $8.7 million in 2021.
- As far as peak fluctuations go, Mainz Biomed's Cash & Current Investments skyrocketed by 702057.14% in 2021, and later tumbled by 9429.6% in 2024.
- Quarter analysis of 5 years shows Mainz Biomed's Cash & Current Investments stood at $8.7 million in 2021, then surged by 96.41% to $17.1 million in 2022, then plummeted by 58.75% to $7.1 million in 2023, then decreased by 11.81% to $6.2 million in 2024, then crashed by 69.35% to $1.9 million in 2025.
- Its Cash & Current Investments stands at $1.9 million for Q2 2025, versus $6.2 million for Q4 2024 and $977764.0 for Q2 2024.